← Back to news
S

Seeking Alpha: News

Brighthouse Financial Inc. - 5.375% PRF PERPETUAL USD 25 - Ser C 1/1000 declares $0.3359 dividend

S

Brighthouse Financial 6.75 DP SHS PF B declares $0.4219 dividend

S

Ternium Q4 2025 Earnings Preview

S

Pan American Silver Q4 2025 earnings preview; stock down ahead of results

S

Brighthouse Financial ADS 6.6% Non-Cum Pref Stk Series A declares $0.4125 dividend

S

Beverage buzz: PepsiCo launches its prebiotic soda nationally

B

Figma teams up with Anthropic to convert AI code into designs

B

'College Football Playoffs' on ESPN drives cable viewership in January - Nielsen

B

CleanSpark tops crypto firms with $2B+ market cap in short interest as of mid-February

B

BitGo Holdings gets new Buy rating at Citi

B

Homebuilder sentiment dropped in February on affordability challenges

B

GSK says RSV shot Arexvy lowers risk of CV events, asthma, and COPD

B

Accenture gets rating upgrade at Wells Fargo

B

A worsening labor market is still the key risk for the U.S. economy – Goldman Sachs

B

Most and least shorted financial stocks with up to $2B market cap

B

ServiceNow edges up after executives cancel stock sale plans

B

Least shorted stocks with up to $2B market cap as of mid-February

B

Most and least shorted financial stocks with market caps above $2B as of mid-february

B

Eagle Point Credit declares $0.14 dividend

B

Most shorted stocks with up to $2B market cap as of mid-February

B

Crypto funds record outflows of $173M last week: report

B

BofA Securities upgrades Equifax, Transunion

B

Conagra Brands backs its full-year guidance ahead of CAGNY presentation

B

Citi downgrades Bath & Body Works as FY26 will show cracks in its core business

B

Nvidia likely to see 'continued strong ramp' with upcoming Rubin GPU sales, Citi says

B

Ormat Technologies signs geothermal PPA with NV Energy for up to 150 MW geothermal capacity

B

CrowdStrike reigns among security vendors as Palo Alto, SentinelOne improve: Oppenheimer

B

Pfizer says cancer therapy Braftovi improved survival in late-stage trial

S

GSK wins approval of Exdensur in Europe for severe asthma

S

Arthur J. Gallagher & Co announces acquisition of B&W Insurance Agency

S

Enagás, S.A. reports FY 2025 results

S

Marriott Vacations Worldwide appoints Matthew Avril as CEO

S

Oxford Lane Capital estimates January NAV of $13.48 - $13.78 per share

S

Macquarie Asset Management to acquire South American tower operations of IHS Towers

S

Lakeland Industries appoints Calven Swinea as CFO

S

Winter weather pushes truckload rates higher in January

S

Basilea Pharmaceutica AG GAAP EPS of CHF 3.14, revenue of CHF 232.4M

S

Stabilis Solutions sees Q4 revenue between $13M and $13.5M

S

Sinch AB (publ) GAAP EPS of SEK 0.31, net sale of SEK 6.76B

S

4 stocks to watch on Tuesday: SHOP, LLY, GIS, NCLH

S

Hillman Solutions Non-GAAP EPS of $0.10 in-line, revenue of $365.1M misses by $6.69M

S

Knife River GAAP EPS of $0.56 beats by $0.16, revenue of $755.1M beats by $28.5M

S

Honeywell revises FY 2025 financials after additional impairment charges

S

YieldMax® Universe Fund of Option Income ETFs declares $0.0778 dividend

S

YieldMax® Magnificent 7 Fund of Option Income ETFs declares $0.1076 dividend

S

Enlight Renewable Energy GAAP EPS of $0.10 misses by $0.03, revenue of $152M misses by $23.25M

S

YieldMax Ultra Option Income Strategy ETF declares $0.436 dividend

S

YieldMax Ultra Short Option Income Strategy ETF declares $0.3696 dividend

S

Ocular drops after late-stage trial data for wet AMD therapy

S

Palo Alto Networks unveils intent to acquire Koi to boost agentic capabilities

S